EUVIMEDEUVIMED entdecken
Crossref

LCAT deficiency promotes hepatocellular carcinoma progression and lenvatinib resistance by promoting triglyceride catabolism and fatty acid oxidation

Min Xu, Peiyi Xie, Shaoqing Liu, Xukang Gao, Shiguang Yang, Zhiqiu Hu, Yue Zhao, Yong Yi, Qiongzhu Dong, Christiane Bruns, Xiaoni Kong, Mien-Chie Hung und 2 weitere

Cancer Letters · 2025

DOI: 10.1016/j.canlet.2025.217469 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2025. Verfasst von Min Xu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Key Laboratory of Carcinogenesis and C…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Quinolines, Phenylurea Compounds. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 79 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsQuinolinesPhenylurea CompoundsFatty AcidsTriglyceridesDrug Resistance, NeoplasmPhosphatidylcholine-Sterol O-AcyltransferaseHumansOxidation-ReductionMaleCell ProliferationAnimalsDisease ProgressionFemaleCaveolin 1Cell Line, TumorMiceCell MovementLipid MetabolismMiddle AgedCarnitine O-Palmitoyltransferase

Stichwörter der Autor:innen

Fatty acid oxidationHepatocellular carcinomaLCATLenvatinibLipolysis

Substanzen

lenvatinibQuinolinesPhenylurea CompoundsFatty AcidsTriglyceridesPhosphatidylcholine-Sterol O-AcyltransferaseCaveolin 1CAV1 protein, humanCPT1A protein, humanCarnitine O-Palmitoyltransferase

Autor:innen und Institutionen

  • Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai, 200032, PR China.
  • Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai, 200032, PR China; Dep…
  • Key Laboratory of Whole-Period Monitoring and Precise Intervention of Digestive Cancer of Shanghai Municipal Health Commission, Shanghai, 201199, PR China; Institute of Fudan-Minhang Academic Health System, Minhang Hosp…
  • Department of General, Visceral, Cancer and Transplantation Surgery, University Hospital of Cologne, Kerpener Straße 62, 50937, Cologne, Germany.
  • Central Laboratory, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, PR China. Electronic address: xiaoni-kong@126.com.
  • Graduate Institute of Biomedical Sciences, Institute of Biochemistry and Molecular Biology, Research Center for Cancer Biology, Cancer Biology and Precision Therapeutics Center, and Center for Molecular Medicine, China…

Zitieren

APA

Xu, M., Xie, P., Liu, S., Gao, X., Yang, S., Hu, Z., Zhao, Y., Yi, Y., Dong, Q., Bruns, C., Kong, X., Hung, M. C., Ren, N., & Zhou, C. (2025). LCAT deficiency promotes hepatocellular carcinoma progression and lenvatinib resistance by promoting triglyceride catabolism and fatty acid oxidation. Cancer Letters. https://doi.org/10.1016/j.canlet.2025.217469

Vancouver

Xu M, Xie P, Liu S, Gao X, Yang S, Hu Z, et al. LCAT deficiency promotes hepatocellular carcinoma progression and lenvatinib resistance by promoting triglyceride catabolism and fatty acid oxidation. Cancer Letters. 2025. doi:10.1016/j.canlet.2025.217469

BibTeX
@article{Xu2025,
  author = {Xu, Min and Xie, Peiyi and Liu, Shaoqing and Gao, Xukang and Yang, Shiguang and Hu, Zhiqiu and Zhao, Yue and Yi, Yong and Dong, Qiongzhu and Bruns, Christiane and Kong, Xiaoni and Hung, Mien-Chie and Ren, Ning and Zhou, Chenhao},
  title = {LCAT deficiency promotes hepatocellular carcinoma progression and lenvatinib resistance by promoting triglyceride catabolism and fatty acid oxidation},
  journal = {Cancer Letters},
  year = {2025},
  doi = {10.1016/j.canlet.2025.217469}
}
Kostenlos starten →